Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program

Litwin AH, Harris KA, Nahvi S, et al. Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. J Subst Abuse Treat. 2009;37(1):32-40.

Publication Type:

Journal Article

Authors:

Litwin, A.H.; Harris, KA; Nahvi, S.; et, al

Source:

J Subst Abuse Treat, Volume 37, Issue 1, p.32-40 (2009)

Keywords:

Adult, Analgesics, Analgesics,Opioid, Antiviral Agents, coinfection, Comorbidity, complications, Diagnosis,Dual (Psychiatry), drug therapy, Drug Therapy,Combination, Drug Users, epidemiology, Female, HCV, hepatitis, Hepatitis C, hepatitis C virus, Hepatitis C,Chronic, Hiv, HIV Infections, Humans, interferon, Interferon Alfa-2a, Interferon Alfa-2b, Interferon-alpha, Internal Medicine, Male, Medicine, Methadone, New York, Opioid-Related Disorders, Patients, peginterferon, peginterferon alfa-2b, pegylated, pegylated interferon, Polyethylene Glycols, Prevalence, Proteins, psychiatric, Recombinant Proteins, rehabilitation, Research, Research Support, Retrospective Studies, Ribavirin, Substance Abuse,Intravenous, therapeutic use, treatment, Treatment Outcome, United States

Notes:

PMC2692471

Cited On:

Management of Acute HCV Infection

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/19038524

Export Citation:

RIS Format

Top